References
- Pepys M B, Baltz M C. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A Protein. Adv Immunol. 1983; 34: 141–212
- Schumann G, Dati F. Vorläufige Referenzbereiche für 14 Proteins im Serum (für Erwachsene) nach Standardisierung immunochemischer Methoden unter Bezug auf das internationale Referenzmaterial CRM 470. Lab Med. 1995; 19: 401–403
- Liuzzo G, Biasucci L M, Gallimore J R, Grillo R L, Rebuzzi A G, Pepys M B, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994; 331: 417–424
- Haverkate F, Thompson S G, Pyke S DM, Gallimore J R, Pepys M B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997; 349: 462–466
- Ridker P M, Cushman M, Stampfer M J, Tracy R P, Hennekens C H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336: 973–979
- Price C P, Trull A K, Berry D, Gormann E G. Development and validation of a particle enhanced turbidimetric immunoassay for C-reactive protein. J Immunol Methods. 1987; 99: 205–211
- Lammers M, Bienvenu J, Monneret G, Borque de Larrea L, Gaona N, Schumann G, Stevens W J, Van Campenhout C. Evaluation of an improved immunonephelometric assay for C-reactive protein. Clin Chem. 1996; 42: S165, (Abstract)
- Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal. 1998; 12: 137–144
- Schwartz M W, Schifreen R S, Gorman E, Tuhy P M, Bienvenu J, Warkentin D L. Development and performance of a fully automated method for assay of C-reactive protein in the aca discrete clinical analyser. Clin Chem. 1988; 34: 1646–164